Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 1 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy.
J Hematol Oncol. 2022 Jul 7;15(1):89. doi: 10.1186/s13045-022-01310-7.
J Hematol Oncol. 2022.
PMID: 35799213
Free PMC article.
Review.
A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin.
Xian J, Bu F, Wang Y, Long F, Zhang Z, Wu C, Tao Y, Wang T, Wang G.
Xian J, et al.
Molecules. 2021 Feb 10;26(4):946. doi: 10.3390/molecules26040946.
Molecules. 2021.
PMID: 33579052
Free PMC article.
Item in Clipboard
Non-IL-2-blocking anti-CD25 antibody inhibits tumor growth by depleting Tregs and has synergistic effects with anti-CTLA-4 therapy.
Peng Y, Fu Y, Liu H, Zhao S, Deng H, Jiang X, Lai Q, Lu Y, Guo C, Zhang G, Luo Y, Wang Y, Gou L, Yang J.
Peng Y, et al.
Int J Cancer. 2024 Apr 1;154(7):1285-1297. doi: 10.1002/ijc.34823. Epub 2024 Jan 5.
Int J Cancer. 2024.
PMID: 38180065
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.